Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
News Medical on MSN4h
Research identifies iron as crucial driver of stroke-related cell death processesIschemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
A pivotal study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
The FDA said to stop all use of Philips' Tack Endovascular System, which is under class I recall for user difficulties in ...
CricTracker on MSN12h
Should Rohit Sharma curb his aggression vs Australia? Manjrekar and Kumble debateAhead of the Champions Trophy 2025 semi-final, find out why cricket legends Sanjay Manjrekar and Anil Kumble want India ...
Dr. Michael Chenier with Mission Hospital writes that knowing symptoms of heart disease and getting screened shoule be a ...
U.S. President Donald Trump hinted on Monday that a deal to open up Ukraine's minerals to U.S. investment could still be ...
Trump slams ‘Governor Trudeau of Canada’ in escalating tariff trade war that caused market plunge: Live - President’s trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback